Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Exercise hormone irisin mitigates endothelial barrier dysfunction and microvascular leakage–related diseases
Jianbin Bi, Jia Zhang, Yifan Ren, Zhaoqing Du, Yuanyuan Zhang, Chang Liu, Yawen Wang, Lin Zhang, Zhihong Shi, Zheng Wu, Yi Lv, Rongqian Wu
Jianbin Bi, Jia Zhang, Yifan Ren, Zhaoqing Du, Yuanyuan Zhang, Chang Liu, Yawen Wang, Lin Zhang, Zhihong Shi, Zheng Wu, Yi Lv, Rongqian Wu
View: Text | PDF
Research Article Cell biology Vascular biology

Exercise hormone irisin mitigates endothelial barrier dysfunction and microvascular leakage–related diseases

  • Text
  • PDF
Abstract

Increased microvascular leakage is a cardinal feature of many critical diseases. Regular exercise is associated with improved endothelial function and reduced risk of cardiovascular disease. Irisin, secreted during exercise, contributes to many health benefits of exercise. However, the effects of irisin on endothelial function and microvascular leakage remain unknown. In this study, we found that irisin remarkably strengthened endothelial junctions and barrier function via binding to integrin αVβ5 receptor in LPS-treated endothelial cells. The beneficial effect of irisin was associated with suppression of the Src–MLCK–β-catenin pathway, activation of the AMPK-Cdc42/Rac1 pathway, and improvement of mitochondrial function. In preclinical models of microvascular leakage, exogenous irisin improved pulmonary function, decreased lung edema and injury, suppressed inflammation, and increased survival. In ARDS patients, serum irisin levels were decreased and inversely correlated with disease severity and mortality. In conclusion, irisin enhances endothelial barrier function and mitigates microvascular leakage–related diseases.

Authors

Jianbin Bi, Jia Zhang, Yifan Ren, Zhaoqing Du, Yuanyuan Zhang, Chang Liu, Yawen Wang, Lin Zhang, Zhihong Shi, Zheng Wu, Yi Lv, Rongqian Wu

×

Figure 6

Irisin protected mitochondrial function in endothelial cells to restore endothelial barrier integrity.

Options: View larger image (or click on image) Download as PowerPoint
Irisin protected mitochondrial function in endothelial cells to restore ...
HMVECs were treated with 10 nM irisin immediately after 500 ng/mL LPS administration. (A–C) Western blot analysis of the expression of PPARγ coactivator 1α (PGC-1α) and mitochondrial transcription factor (TFAM) in HMVECs 2 hours and 8 hours after LPS treatment. (D and E) Western blot analysis of PGC-1α expression in irisin- and LPS-treated HMVECs transfected with nonspecific siRNA or AMPK siRNA. (F and G) MitoTracker Red CMXRos fluorescence staining and fluorescence intensity of HMVECs 2 hours after LPS, irisin, and AMPK siRNA treatment. Scale bar: 10 μm. (H–J) Western blot analysis of the expression of ATP synthase β (ATPB) and PTEN-induced putative kinase 1 (PINK-1) in HMVECs. (K) ATP concentration 2 hours and 8 hours after irisin and LPS treatment in HMVECs. (L and M) Western blot analysis of uncoupling protein 2 (UCP2) expression in HMVECs. (N and O) DHE fluorescence staining and its fluorescence intensity of HMVECs at 2 hours after LPS and irisin treatment. Scale bar: 20 μm. n = 6 per group, mean ± SEM, *P < 0.05 versus the sham group or LPS + irisin group, #P < 0.05 versus the LPS group. One-way ANOVA was used to analyze the differences between groups.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts